| Literature DB >> 32373477 |
Janiel K Ahkin Chin Tai1, Jennifer L Freeman1.
Abstract
Zebrafish (Danio rerio) are an integrative vertebrate model ideal for toxicity studies. The zebrafish genome is sequenced with detailed characterization of all life stages. With their genetic similarity to humans, zebrafish models are established to study biological processes including development and disease mechanisms for translation to human health. The zebrafish genome, similar to other eukaryotic organisms, contains microRNAs (miRNAs) which function along with other epigenetic mechanisms to regulate gene expression. Studies have now established that exposure to toxins and xenobiotics can change miRNA expression profiles resulting in various physiological and behavioral alterations. In this review, we cover the intersection of miRNA alterations from toxin or xenobiotic exposure with a focus on studies using the zebrafish model system to identify miRNA mechanisms regulating toxicity. Studies to date have addressed exposures to toxins, particulate matter and nanoparticles, various environmental contaminants including pesticides, ethanol, and pharmaceuticals. Current limitations of the completed studies and future directions for this research area are discussed.Entities:
Keywords: Epigenetics; Toxicology; Zebrafish; miRNA; microRNA
Year: 2020 PMID: 32373477 PMCID: PMC7195498 DOI: 10.1016/j.toxrep.2020.03.010
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
Fig. 1Zebrafish life cycle. Images are of an embryo at 1 h post fertilization (hpf), an eleutheroembryo at 5 days post fertilization (dpf), and adult female (top) and male (bottom) zebrafish.
Fig. 2Total number of mature miRNAs currently identified in zebrafish, mouse, and human genomes. Numbers were attained from the latest version of miRbase release 22.1 (October 2018).
miRNA regulation of toxins found to contaminate food and water sources.
| Toxin | Time of exposure | miRNAs | Health endpoints | References |
|---|---|---|---|---|
| 50 μM citrinin | 24−72 hpf | miR-138 | Decreased expression, leading to lower survival, abnormal heart looping, pericardial edema, cardiac ischemia, miR-138 rescue reduced symptoms and increased survival | [ |
| miR-218a | Decreased expression but didn’t effect cardiac endpoints assessed | |||
| 0.5 μM ochratoxin | 6−72 hpf | miR-731 | Increased expression, leading to decreased expression of renal genes and morphological defects | [ |
| 0.5 μM ochratoxin | 6−72 hpf | miR-731 | Increased expression, leading to decreased expression of vasculature genes and cerebral vasculature loss | [ |
| 12−48 μM Microcystin-RR | 0.75−24 hpf | miR-146a | Up regulation | [ |
| miR-190b | Down regulation | |||
| miR-126-DP | Down regulation - Rescue partially restores vascularization | |||
| miR-430 | Up regulation | |||
| miR-126 | Up regulation |
miRNA regulation of particulate matter and nanoparticle toxicity response.
| Xenobiotic | Time of exposure | miRNAs | Health endpoints | References |
|---|---|---|---|---|
| 100 μg/ml PM2.5 | 6−120 hpf | let-7b | Up regulation - Regulates genes in DNA repair and breast cancer | [ |
| miR-153 | Up regulation - Associated with hypertension in rats | |||
| miR-122 | Up regulation - Regulates hypoxia based glucose metabolism | |||
| miR-24 | Up regulation - Roles in immunity and inflammation | |||
| let-7i let-7i | Down regulation - Role in immunity | |||
| miR-7a/b | Down regulation - Cardiomyocyte protective | |||
| miR-19b-3p | Down regulation - Inhibits cardiac fibrogenesis | |||
| 3 mg/mL Silica nanoparticle, 0.01 mg/ml MeHg | 48 hpf | miR-7147, miR-26a | Down regulation | [ |
| miR-26amiR-375, miR-206 | Up regulation(Many miRNAs and genes assessed but the authors focused on these miRNAs that were part of a pathway for cardiac muscle contraction) | |||
| miR-124 | Key regulator for Wnt signaling and implicated in DNA double strand damage | [ | ||
| miR-144 | Key mediator for oxidative stress | |||
| miR-19a | Important in oncogene regulation and in inflammatory responses | |||
| miR-155a | Inflammatory response mediator with MAPK and TNF signaling as candidate pathways | |||
| miR-223 | Predicted in three networks as a key regulator in tissue damage |
miRNA regulation of pesticide toxicity response.
| Xenobiotic | Time of exposure | miRNAs | Health endpoints | References |
|---|---|---|---|---|
| 0, 4, 4.40, 4.84, 5.32, 5.86 or 6.44 mg/l of 30 % triazophos microemulsifier.0.050, 0.080, 0.128, 0.205, 0.328 or 0.524 mg/l for 1% fipronil ME;1.5, 1.8, 2.16, 2.59, 3.11, or 3.73 mg/l for 31 % triazophos + fipronil ME | 96 h adult exposure | miR-135c, miR-30b, miR-365 | Decrease expression with triazophos exposure | [ |
| miR-21, miR-31, miR-203b, miR-455 | Increased expression with triazophos exposure | |||
| miR-199, miR-22b, miR-499 | Decreased expression with fipronil exposure | |||
| miR-128, miR-9 | Decreased expression with mixture | |||
| miR-735 | Increased expression with mixture | |||
| miR-181a, let-7i, miR-203b | Increased expression with ME formulation | |||
| miR-155, miR-99 | Decreased expression with ME formulation | |||
| 0.034, 0.068, 0.137, 0.274, 0.548, 1.098 μM fipronil | 96 h adult exposure | miR-155 | Dose dependent down regulation - Associated with increase in | [ |
| 0.034, 0.068, 0.137, 0.274, 0.548, 1.098 μM fipronil | 96 h adult exposure | miR-216b, miR-499 | Down regulated and interacts with the gene | [ |
| 0.45, 0.9, 1.8, or 3.6 μg/ml triazophos | 96 h adult exposure | miR-217 | Dose dependent down regulation - Suggested as a biomarker for triazophos | [ |
| 0, 0.3, 3, or 30 μg/l atrazine | 1 hpf to 12, 24, 36, 48, 60 or 72 hpf | miR-126 | Dose dependent up regulation at 36 hpf, suppression at 48 hpf, and up regulation at 60 hpf in 30 μg/l treatment group - Associated with hemorrhage, vascular remodeling and maturation effects in zebrafish embryogenesis | [ |
| hsa-miR-126-3p | Altered in all 3 concentrations - Important for tumor suppression in several cancers, angiogenesis, and inflammation | |||
| miR-10 | miR-10 family regulates hox genes, specifically | |||
| miR-23a, miR-24 | Regulates angiogenesis | |||
| miR-16a, miR-16b | Key epigenetic factors in identifying prostate, breast and gastric cancer | |||
| miR-18a, miR-18b-5p | Highly expressed in several types of cancer | |||
| miR-143, miR-216b, miR-217 | Important for tumor suppression | |||
| miR-26a | Altered at 30 μg/l - Regulates neurogenesis | |||
| miR-124 | Decreased expression at 30 μg/l - Important for neurogenesis |
miRNA regulation of environmental contaminants.
| Xenobiotic | Time of exposure | miRNAs | Health endpoints | References |
|---|---|---|---|---|
| 5 nM TCDD | 30 hpf for 1 h Assessed at 36 and 60 hpf | miR-24 | Up regulation - Proposed regulation of cardiac myocyte apoptosis and cardiac fibrosis | [ |
| miR-27 | Down regulation - Proposed dysregulation of erythropoiesis regulation and maturation | |||
| miR-144, miR-451 | Up regulation - Proposed cardiac hypertrophy | |||
| miR-23a, miR-204 | Down regulation - Reduced expression of claudin proteins involved in tight junctions | |||
| 62.5, 125, or 250 μg/l triclosan | 4−96 hpf | miR-125b | Dose dependent dysregulation – Involved in fatty acid synthesis and metabolism | [ |
| miR-205 | Dose dependent up regulation – Involved with DNA repair/cell cycle | |||
| miR-142a | Dose dependent up regulation – Associated with the P53 signaling pathway | |||
| miR-203a | Dose dependent up regulation – Associated with fatty acid synthesis and metabolism | |||
| 62.5, 125, or 250 μg/l triclosan | 6−120 hpf, | miR-137 | Up regulation in visceral mass, forebrain and olfactory bulb; Down regulation of regulatory genes | [ |
| 2, 20, or 200 nM Hexa-bromocyclododecane (HBCD) | 1−72 hpf | miR-1 | Down regulation associated with cardiac hypertrophy and downregulation of | [ |
| miR-219, miR-145, miR-194b, miR-221, miR-146b | All up regulated, except miR-146b, which was down regulated and is important for cardiovascular related diseases | |||
| 1 μg/mL | 6 hpf to 24 or 120 hpf | miR-19d, miR-739 | Up regulated - Associated with inhibiting tumor cell proliferation by repressing p27 | [ |
| miR-19b-c | Up regulated - Targets genes important in brain and nervous system development | |||
| 6.3, 16, or 40 μg/l CuCl2 | 12 mpf zebrafish exposed for 24 h | miR-187, miR-140 | Altered in all concentrations | [ |
| miR-203a, miR-199*, miR-16a, miR-16c, miR-25 | Up regulated - Associated with mRNA levels of host genes in Ca signaling | |||
| miR-193b, miR-214, miR-183, miR-140* | Down regulated | |||
| let-7 a, e, f, g, h, i | Up regulated - Associated with regulation of development and neurogenesis | |||
| miR-7a | Up regulated - Associated with down regulation of target cytokine signaling 1 | |||
| miR-128 | Up regulated - Associated with neural differentiation | |||
| miR-724, miR-187, miR-126, miR-30c, miR-16c, miR-203a, miR-203b | Up regulated - Associated with neurogenesis | |||
| 5, 50 μg/l bisphenol S | 3−4 mpf adult male zebrafish exposed for 21 d | miR-184, miR-27e, miR-122, miR-204, miR-430a | Uniquely regulated at 5 μg/L | [ |
| miR-205 | Up regulated - Targets | |||
| miR-30c, miR-192, miR-430b, miR-454b, miR-499 | Down regulated - Targets | |||
| miR-223, miR-363 | Down regulated | |||
| miR-193b | Up regulated | |||
| 100 nM bisphenol A | 3 weeks in male zebrafish | miR-2189 | Down regulated - Associated with genes regulating cell cycle | [ |
| miR-430b | Upregulated - Associated with apoptosis and autophagy | |||
| miR-724, miR-725, miR-193a, miR-202, miR-205, miR-133a | Targets several genes in oxidative phosphorylation, apoptosis, and cell cycle | |||
| 0.125, 0.5, 1.0 mg/l PCB 1254 | 24−120 hpf | miR-21 | Dose dependent up regulation. - Associated with the loss of calcium in zebrafish skeleton | [ |
miRNA regulation of ethanol exposure.
| Xenobiotic | Time of exposure | miRNAs | Health endpoints | References |
|---|---|---|---|---|
| 1 or 1.5 % ethanol | 4−24 hpf | miR-153a, miR-725, miR-30d, miR-let-7k, miR-100, miR-738, miR-732 | Up regulated in both exposures | [ |
| 430 μM ethanol | 3.5−7.5 hpf | miR-9 | Down regulated - Decreased methylation and decreased expression of | [ |
| Up to 300 mM ethanol | 4−24 hpf | miR-153c, miR-204 | Down regulated - Role in altered locomotion | [ |
| miR-9 | Down regulated – Associated with craniofacial skeletal development | |||
| 0.5% ethanol | 8 weeks in adult zebrafish | miR-140−3p | Down regulated - Targets | [ |
| miR-146 | Up regulated - Targets Notch signaling to suppress myogenesis |
miRNA regulation of pharmaceuticals.
| Pharmaceutical | Time of exposure | miRNAs | Health endpoints | References |
|---|---|---|---|---|
| 54 μg/l Fluoxetine | 3−144 hpf | miR-181a | Up regulated in ovary and fin tissue of exposed females | [ |
| miR-740 | Down regulated in eggs - Targets multiple stress axis transcripts | |||
| miR-26a, miR-30d, miR-92a, miR-103, miR-30d, miR-92a | Up regulated in eggs from 5 mpf females; Down regulated in eggs from 9 mpf females - miRNA changes transcripts in eggs with reduction of transcripts in eggs from treated females at 5 mpf and increased at 9 mpf | |||
| 540 ng/l fluoxetine | 7 days in adult females | let-7d, miR-140−5p, miR-301a, miR-457b | Up regulated - Similar miRNA expression profile of fluoxetine exposed animals and animals that were fasted | [ |
| 1 mM valproic acid | 4–48 or 96 hpf | miR-16a, miR-18c, miR-22a, miR-457b | Up regulated at 48 hpf | [ |
| miR-96, miR-122, miR-124, miR-132, miR-135a, miR-140, miR-182, miR-182*, miR-724 | Down regulated 48 hpf | |||
| miR-10b, miR-10c, miR-16a, miR-16b, miR-18c, miR-22b, miR-210*, miR-217, miR-451, miR-455, miR-457b | Up regulated at 96 hpf | |||
| miR-10b, miR-10c | Up regulated - Regulates hox genes for anterior posterior development | |||
| miR-21, miR-27c, miR-34, miR-122, miR-192, miR-194a, miR-724 | Down regulated at 96 hpf | |||
| miR-29a, miR-29b | Down regulated - Important for neuron survival | |||
| miR-132, miR-212 | Down regulated - Important for neurogenesis | |||
| 1 μg/l | Adults exposed for 21 days | miR-22b-3p, miR-301a | Down regulated - Gene enrichment shows metabolic pathways such as drug metabolism is altered; Observation not seen after recovery period | [ |
| 0.5, 1, 2 μM tamoxifen | 4 dpf for 24 h | miR-122 | Decreased miRNA-122 expression with increasing tamoxifen concentration in adults; Increased miRNA expression with acetaminophen exposure | [ |
| 20−40 mM acetaminophen | Adult fish (5−24 mpf) exposed for 3 h | miR-122 | Dose dependent increase in circulating expression, which was associated with hepatotoxicity | [ |
| 5 nM retinoic acid | 6−24 hpf | miR-19a, miR-19c, miR-19d | Decreased expression - Targets | [ |
| 6.25 mg/l total composed of: | 4 hpf - 90 dpf | miR-124, miR-124−3p | Up regulated in 6.25 mg/l treatment; Down regulated in 12.5 mg/l | [ |
| miR-22a-3p, miR-143, miR-10c-5p, miR-92−3p, miR-148, miR-152, miR-30e, miR-181a-3p, miR-95−5p, miR-184−3p | Dose dependent down regulation in eye and otocyst and decreased expression with ISH -Associated with retinal photoreceptor cysts and larval decreased volume of larval otocyst | |||
| miR-184, miR-96 | Down regulated in atrium - Associated with atrium tissue damage | |||
| miR-92a | Down regulated in the liver - Associated with hepatic parenchyma vacuolar degeneration; Down regulated and reduced expression in the heart - Associated with atrial muscle cysts | |||
| miR-10c | Dose dependent down regulation - Associated with reduced and swollen hepatocytes | |||
| 25 mg/l total, composed of ofloxacin (11.5 μmol/L), ciprofloxacin (12.6 μmol/L), enrofloxacin (11.6 μmol/L), doxycycline (8.1 μmol/L), chlortetracycline (8.1 μmol/L), and oxytetracycline (9.0 μmol/L) | 2−120 hpf | miR-184 | Dose dependent down regulation in otoliths - Associated with delayed otolith development; Rescue improved otic vesicle phenotype | [ |
| miR-96 | Dose dependent down regulation in otolith - Injection improved otic vesicle phenotype; Rescue restores hair cell numbers following exposure | |||
| 6.25 mg/l total composed of: | 6 hpf - 3 mpf in F0 fish | miR-125b, miR-430c | Dose dependent increased expression in the F0 adult ovary | [ |
| miR-124, miR-499 | Highly expressed in the liver, brain, gills, reproductive gills and cloaca of F1 larvae at 7 dpf | |||
| 12.5 or 25.0 mg/l total exposure to | 6 hpf- 90 dpf | miR-125b, miR-144 | Increased expression in F0 adult and F1 larvae at 5 dpf - Target genes identified were | [ |